Reducing childhood mortality in poor countries - Antenatal and perinatal strategies to prevent mother-to-child transmission of HIV infection

被引:15
作者
Newell, ML [1 ]
机构
[1] Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London WC1N 1EH, England
关键词
HIV; vertical transmission; infant delivery; breastfeeding; antiretroviral therapy;
D O I
10.1016/S0035-9203(03)90009-5
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Mother-to-child transmission (MTCT) is the dominant mode of acquisition of HIV infection for children. Each day an estimated 1600 children born to HIV-infected mothers become infected, 1500 of whom are in sub-Saharan Africa. Mother-to-child transmission can occur before, during and after delivery; overall rates of MTCT range from 15 to 35%. Risk factors for MTCT include maternal viral load levels, vaginal delivery, prematurity and breastfeeding. Approaches to reduce the risk of MTCT include reduction of maternal viral load through antiretroviral prophylaxis, avoidance of exposure through birth canal cleansing or elective caesarean section delivery and refraining from breastfeeding, and boosting the host immune system through nutritional supplementation or immunization. Substantial reductions in the risk of MTCT can be achieved with antiretroviral prophylaxis during pregnancy, delivery and in the neonatal period, both in settings with and without breastfeeding. Elective caesarean section independently decreases the risk, but is not a safe and feasible option in most high prevalence areas. Birth canal cleansing with chlorhexidine does not reduce the rate overall, but may be beneficial in a subgroup of women with prolonged duration of ruptured membranes. Micronutrient supplementation, including vitamin A, does not reduce MTCT of HIV, but may improve pregnancy outcome generally.
引用
收藏
页码:22 / 24
页数:3
相关论文
共 16 条
[1]  
Aebi C, 2000, AIDS, V14, P2913, DOI 10.1097/00002030-200012220-00013
[2]   The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1 -: A meta-analysis of 15 prospective cohort studies [J].
Andiman, W ;
Boucher, M ;
Burns, D ;
Bryson, Y ;
Farley, J ;
Fowler, H ;
Gabiano, C ;
Galli, L ;
Hutto, C ;
Kind, C ;
Korber, B ;
Kovacs, A ;
Krogstad, P ;
Landesman, S ;
Lapointe, N ;
Lemay, M ;
Lew, J ;
Mandelbrot, L ;
Mayaux, MJ ;
Mellins, R ;
Minkoff, H ;
Mofenson, L ;
Nielsen, K ;
Newell, ML ;
Pardi, G ;
Peavy, H ;
Peckham, C ;
Read, J ;
Rother, C ;
Rudin, C ;
Scott, G ;
Semprini, A ;
Shearer, W ;
Simonds, R ;
Simpson, B ;
Stek, A ;
Tovo, PA ;
Tuomala, R ;
Van Dyke, R ;
Weedon, J ;
de Martino, M ;
Lindsay, M ;
Belair, S ;
Chan, L ;
Harris, D ;
Kalish, L ;
Muenz, L ;
Nugent, R ;
Schluchter, M ;
Durako, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (13) :977-987
[3]  
Bailey A, 1999, AIDS, V13, P1377, DOI 10.1097/00002030-199907300-00016
[4]   Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues [J].
Blanche, S ;
Tardieu, M ;
Rustin, P ;
Slama, A ;
Barret, B ;
Firtion, G ;
Ciraru-Vigneron, N ;
Lacroix, C ;
Rouzioux, C ;
Mandelbrot, L ;
Desguerre, I ;
Rötig, A ;
Mayaux, MJ ;
Delfraissy, JF .
LANCET, 1999, 354 (9184) :1084-1089
[5]   Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women [J].
Culnane, M ;
Fowler, M ;
Lee, SS ;
McSherry, G ;
Brady, M ;
O'Donnell, K ;
Mofenson, L ;
Gortmaker, SL ;
Shapiro, DE ;
Scott, G ;
Jimenez, E ;
Moore, EC ;
Diaz, C ;
Flynn, PM ;
Cunningham, B ;
Oleske, J .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 281 (02) :151-157
[6]   Preventing mother-to-child transmission of HIV-1 in Africa in the year 2000 [J].
Dabis, F ;
Leroy, V ;
Castetbon, K ;
Spira, R ;
Newell, ML ;
Salamon, R .
AIDS, 2000, 14 (08) :1017-1026
[7]   Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVMET 012 randomised trial [J].
Guay, LA ;
Musoke, P ;
Fleming, T ;
Bagenda, D ;
Allen, M ;
Nakabiito, C ;
Sherman, J ;
Bakaki, P ;
Ducar, C ;
Deseyve, M ;
Emel, L ;
Mirochnick, M ;
Fowler, MG ;
Mofenson, L ;
Miotti, P ;
Dransfield, K ;
Bray, D ;
Mmiro, F ;
Jackson, JB .
LANCET, 1999, 354 (9181) :795-802
[8]   Lack of tumors in infants with perinatal HIV-1 exposure and fetal/neonatal exposure to zidovudine [J].
Hanson, IC ;
Antonelli, TA ;
Sperling, RS ;
Oleske, JM ;
Cooper, E ;
Culnane, M ;
Fowler, MG ;
Kalish, LA ;
Lee, SS ;
McSherry, G ;
Mofenson, L ;
Shapiro, DE .
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 20 (05) :463-467
[9]  
Newell ML, 2001, B WORLD HEALTH ORGAN, V79, P1138
[10]   Mechanisms and timing of mother-to-child transmission of HIV-1 [J].
Newell, ML .
AIDS, 1998, 12 (08) :831-837